{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:38:17Z","timestamp":1756312697533},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,3]]},"DOI":"10.7759\/cureus.33328","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T03:44:00Z","timestamp":1672803840000},"source":"Crossref","is-referenced-by-count":2,"title":["Does Zoledronic Acid Provide a Good Clinical Outcome in Patients With Chronic Back Pain Associated With Vertebral Osteoporosis?"],"prefix":"10.7759","author":[{"given":"Umesh","family":"M","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhu","family":"Ethiraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyad M","family":"Nazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Agarawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun H","family":"Shanthappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4172\/2329-9509.1000104","article-title":"The effect of parity on bone mineral density in postmenopausal women: a systematic review","volume":"1","author":"Bayray A","year":"2013","unstructured":"Bayray A, Enquselassie F. The effect of parity on bone mineral density in postmenopausal women: a systematic review. J Osteopor Phys Act. 2013, 1:104. 10.4172\/2329-9509.1000104","journal-title":"J Osteopor Phys Act"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4172\/2329-9509.1000206","article-title":"Importance of recognition of osteoporosis and the radiologic diagnosis using DEXA technique","volume":"5","author":"Aldosh M","year":"2017","unstructured":"Aldosh M. Importance of recognition of osteoporosis and the radiologic diagnosis using DEXA technique. J Osteopor Physical Act. 2017, 5:206. 10.4172\/2329-9509.1000206","journal-title":"J Osteopor Physical Act"},{"key":"ref3","article-title":"Osteoporosis: a review of treatment options","volume":"43","author":"Tu KN","year":"2018","unstructured":"Tu KN, Lie JD, Wan CK, et al.. Osteoporosis: a review of treatment options. P T. 2018, 43:92-104.","journal-title":"P T"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2018\/34109.11269","article-title":"Prevalence of osteopenia and osteoporosis in orthopaedic outpatients in Southern India","volume":"12","author":"Chitten JJ","year":"2018","unstructured":"Chitten JJ, James B. Prevalence of osteopenia and osteoporosis in orthopaedic outpatients in Southern India. J Clin Diagn Res. 2018, 12:14-17. 10.7860\/JCDR\/2018\/34109.11269","journal-title":"J Clin Diagn Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v4i12.27","article-title":"The prevalence of osteoporosis and osteopenia in persons above 50 years attending a tertiary care hospital in South India","volume":"4","author":"Hemalata","year":"2016","unstructured":"Hemalata, Reeba MM, Sreekala VK. The prevalence of osteoporosis and osteopenia in persons above 50 years attending a tertiary care hospital in South India. J Med Sci Clin Res. 2016, 4:14458-14462. 10.18535\/jmscr\/v4i12.27","journal-title":"J Med Sci Clin Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4172\/2329-9509.1000114","article-title":"An overview on the approaches to osteoporotic vertebral fractures management","volume":"114","author":"Moroni A","year":"2014","unstructured":"Moroni A. An overview on the approaches to osteoporotic vertebral fractures management. J Osteopor Phys Act. 2014, 114:114. 10.4172\/2329-9509.1000114","journal-title":"J Osteopor Phys Act"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10041","article-title":"Optimizing sequential and combined anabolic and antiresorptive osteoporosis therapy","volume":"2","author":"Leder BZ","year":"2018","unstructured":"Leder BZ. Optimizing sequential and combined anabolic and antiresorptive osteoporosis therapy. JBMR Plus. 2018, 2:62-68. 10.1002\/jbm4.10041","journal-title":"JBMR Plus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4997\/JRCPE.2013.314","article-title":"The history of osteoporosis: why do Egyptian mummies have porotic bones?","volume":"43","author":"Stride PJ","year":"2013","unstructured":"Stride PJ, Patel N, Kingston D. The history of osteoporosis: why do Egyptian mummies have porotic bones?. J R Coll Physicians Edinb. 2013, 43:254-261. 10.4997\/JRCPE.2013.314","journal-title":"J R Coll Physicians Edinb"},{"key":"ref9","article-title":"Control mechanisms in bone resorption: 240 years after John Hunter","volume":"79","author":"Meikle MC","year":"1997","unstructured":"Meikle MC. Control mechanisms in bone resorption: 240 years after John Hunter. Ann R Coll Surg Engl. 1997, 79:20-27.","journal-title":"Ann R Coll Surg Engl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-019-00721-5","article-title":"Romosozumab: a\u00a0novel bone anabolic treatment option for osteoporosis?","volume":"170","author":"Kerschan-Schindl K","year":"2020","unstructured":"Kerschan-Schindl K. Romosozumab: a\u00a0novel bone anabolic treatment option for osteoporosis?. Wien Med Wochenschr. 2020, 170:124-131. 10.1007\/s10354-019-00721-5","journal-title":"Wien Med Wochenschr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1280455","article-title":"Romosozumab for the treatment of osteoporosis","volume":"17","author":"Bandeira L","year":"2017","unstructured":"Bandeira L, Lewiecki EM, Bilezikian JP. Romosozumab for the treatment of osteoporosis. Expert Opin Biol Ther. 2017, 17:255-263. 10.1080\/14712598.2017.1280455","journal-title":"Expert Opin Biol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s40199-017-0167-z","article-title":"New horizons in treatment of osteoporosis","volume":"25","author":"Tabatabaei-Malazy O","year":"2017","unstructured":"Tabatabaei-Malazy O, Salari P, Khashayar P, Larijani B. New horizons in treatment of osteoporosis. Daru. 2017, 25:2. 10.1186\/s40199-017-0167-z","journal-title":"Daru"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S7322","article-title":"Zoledronic acid infusion for prevention and treatment of osteoporosis","volume":"2","author":"Sunyecz JA","year":"2010","unstructured":"Sunyecz JA. Zoledronic acid infusion for prevention and treatment of osteoporosis. Int J Womens Health. 2010, 2:353-360. 10.2147\/IJWH.S7322","journal-title":"Int J Womens Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-64","article-title":"Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging","volume":"15","author":"Koivisto K","year":"2014","unstructured":"Koivisto K, Kyll\u00f6nen E, Haapea M, et al.. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging. BMC Musculoskelet Disord. 2014, 15:64. 10.1186\/1471-2474-15-64","journal-title":"BMC Musculoskelet Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5\u2009mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll ES","year":"2010","unstructured":"Orwoll ES, Miller PD, Adachi JD, et al.. Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5\u2009mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res. 2010, 25:2239-2250. 10.1002\/jbmr.119","journal-title":"J Bone Miner Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.292","article-title":"Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial","volume":"26","author":"Cauley JA","year":"2011","unstructured":"Cauley JA, Black D, Boonen S, et al.. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. J Bone Miner Res. 2011, 26:984-992. 10.1002\/jbmr.292","journal-title":"J Bone Miner Res"},{"key":"ref17","article-title":"Study of effect of zoledronic acid in patients with low back pain associated with vertebral osteoporosis","volume":"3","author":"Ramalingaiah A","year":"2016","unstructured":"Ramalingaiah A, Sridhar R. Study of effect of zoledronic acid in patients with low back pain associated with vertebral osteoporosis. Int J Orthop Traumatol Surg Sci. 2016, 3:367-370.","journal-title":"Int J Orthop Traumatol Surg Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116227-does-zoledronic-acid-provide-a-good-clinical-outcome-in-patients-with-chronic-back-pain-associated-with-vertebral-osteoporosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:38Z","timestamp":1707508058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116227-does-zoledronic-acid-provide-a-good-clinical-outcome-in-patients-with-chronic-back-pain-associated-with-vertebral-osteoporosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.33328","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}